Rick Wise
Stock Analyst at Stifel Nicolaus
(0.38)
# 4,254
Out of 4,564 analysts
810
Total ratings
45.6%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintained: Buy | $120 | $97.88 | +22.60% | 25 | Jul 20, 2026 | |
| ISRG Intuitive Surgical | Rated: Buy | $670 → $550 | $331.73 | +65.80% | 49 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Hold | $250 → $260 | $258.07 | +0.75% | 31 | Jul 15, 2026 | |
| KMTS Kestra Medical Technologies | Maintained: Buy | $30 | $21.24 | +41.24% | 8 | Jul 15, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $40 | $24.01 | +66.60% | 6 | Jul 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $75 → $65 | $43.12 | +50.74% | 66 | Jun 25, 2026 | |
| MDT Medtronic | Maintained: Hold | $95 → $80 | $81.84 | -2.25% | 50 | Jun 3, 2026 | |
| AORT Artivion | Maintained: Buy | $45 | $24.80 | +81.45% | 20 | Jun 1, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $215 → $175 | $152.22 | +14.97% | 31 | May 8, 2026 | |
| TSX: PRN Profound Medical Corp. | Rated: Buy | $16.89 → $14.07 | $9.57 | +47.07% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $6 | $4.10 | +46.34% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $50 | $37.15 | +34.59% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $32.26 | +54.99% | 34 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $90 | $77.03 | +16.84% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $19 | $21.46 | -11.46% | 36 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 → $360 | $313.24 | +14.93% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $18.55 | +18.60% | 32 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2.5 | $1.18 | +111.86% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $105 | $88.48 | +18.67% | 47 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $98 → $80 | $61.52 | +30.04% | 16 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $83.51 | +31.72% | 50 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $100.23 | +19.72% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $3.92 | -23.47% | 24 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $80 | $77.48 | +3.25% | 36 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $24.99 | n/a | 32 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 | $41.10 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.0001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.15 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $34 | $16.20 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $537.31 | n/a | 2 | Nov 8, 2012 |
LeMaitre Vascular
Jul 20, 2026
Maintained: Buy
Price Target: $120
Current: $97.88
Upside: +22.60%
Intuitive Surgical
Jul 17, 2026
Rated: Buy
Price Target: $670 → $550
Current: $331.73
Upside: +65.80%
Johnson & Johnson
Jul 15, 2026
Maintained: Hold
Price Target: $250 → $260
Current: $258.07
Upside: +0.75%
Kestra Medical Technologies
Jul 15, 2026
Maintained: Buy
Price Target: $30
Current: $21.24
Upside: +41.24%
HeartFlow
Jul 15, 2026
Maintained: Buy
Price Target: $40
Current: $24.01
Upside: +66.60%
Boston Scientific
Jun 25, 2026
Maintained: Buy
Price Target: $75 → $65
Current: $43.12
Upside: +50.74%
Medtronic
Jun 3, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $81.84
Upside: -2.25%
Artivion
Jun 1, 2026
Maintained: Buy
Price Target: $45
Current: $24.80
Upside: +81.45%
Becton, Dickinson and Company
May 8, 2026
Maintained: Buy
Price Target: $215 → $175
Current: $152.22
Upside: +14.97%
Profound Medical Corp.
May 8, 2026
Rated: Buy
Price Target: $16.89 → $14.07
Current: $9.57
Upside: +47.07%
May 8, 2026
Rated: Buy
Price Target: $8 → $6
Current: $4.10
Upside: +46.34%
May 8, 2026
Maintained: Buy
Price Target: $55 → $50
Current: $37.15
Upside: +34.59%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $32.26
Upside: +54.99%
May 6, 2026
Maintained: Buy
Price Target: $105 → $90
Current: $77.03
Upside: +16.84%
May 1, 2026
Maintained: Hold
Price Target: $20 → $19
Current: $21.46
Upside: -11.46%
May 1, 2026
Maintained: Buy
Price Target: $440 → $360
Current: $313.24
Upside: +14.93%
May 1, 2026
Reiterated: Buy
Price Target: $22
Current: $18.55
Upside: +18.60%
Apr 30, 2026
Maintained: Buy
Price Target: $5 → $2.5
Current: $1.18
Upside: +111.86%
Apr 29, 2026
Rated: Buy
Price Target: $110 → $105
Current: $88.48
Upside: +18.67%
Apr 29, 2026
Maintained: Buy
Price Target: $98 → $80
Current: $61.52
Upside: +30.04%
Apr 24, 2026
Maintained: Buy
Price Target: $110
Current: $83.51
Upside: +31.72%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $100.23
Upside: +19.72%
Mar 1, 2026
Maintained: Hold
Price Target: $3
Current: $3.92
Upside: -23.47%
Feb 25, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $77.48
Upside: +3.25%
May 7, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $24.99
Upside: n/a
May 1, 2025
Maintained: Hold
Price Target: $55
Current: $41.10
Upside: n/a
Jun 3, 2023
Maintained: Hold
Price Target: $1
Current: $0.0001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.15
Upside: n/a
Aug 22, 2018
Maintained: Hold
Price Target: $25 → $34
Current: $16.20
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $537.31
Upside: n/a